What Is Leigh Syndrome? A Clear Guide for Parents and Caregivers

Roughly 1 in 40,000 newborns receives a diagnosis of this devastating mitochondrial disorder, which typically emerges before a child turns two. It belongs to the broader group of mitochondrial diseases, in which the body’s cellular energy factories cannot keep up with demand, and it ranks among the most severe forms. Most affected children lose motor milestones such as sitting, crawling, or walking, then face progressive weakness, breathing problems, and vision loss.

This guide walks parents and caregivers through what Leigh syndrome really means, from the genetic mutations that derail cellular energy to the first symptoms families tend to notice at home.

Leigh Syndrome as a Rare Neurodegenerative Disorder

First described in 1951 by British neuropathologist Denis Leigh, the condition was originally called subacute necrotizing encephalomyelopathy, a name that captures what he saw under the microscope: patches of damaged, dying tissue scattered through the brainstem and surrounding structures. Nearly seven decades later, the disorder still carries that microscopic signature, even though clinicians now classify it as a mitochondrial encephalopathy, meaning a brain disease driven by faulty cellular energy production.

On the inherited mitochondrial disease spectrum, this diagnosis sits at the severe end. A child who seemed to develop normally for weeks or months may begin losing previously gained abilities, a process called regression of milestones, and that steady backward slide is what separates Leigh syndrome from static disabilities present from birth.

Leigh syndrome affects roughly 1 in 40,000 births, placing it firmly in the rare disease category. Because the number is small, many general pediatricians may see only one or two cases across an entire career, which is why affected families often become the most informed people in the room about their child’s condition.

Why Early Childhood Is the Typical Window

The brain consumes more energy per gram than almost any other organ. When mitochondria falter during a period of rapid neural development, the highest-demand regions, including the brainstem that controls breathing and swallowing, the basal ganglia that coordinate movement, and the thalamus that relays sensory signals, are the first to show damage. That timing explains why symptoms usually surface before age two, though later-onset forms can appear in adolescence or even adulthood.

Those same genetic errors that derail early brain development also sabotage the mitochondria powering every other organ.

How Genetic Mutations Disrupt Mitochondrial Energy Production

At its core, Leigh syndrome is an energy crisis inside cells. Mutations in more than 75 different genes have been linked to the disorder, and those genes sit in two separate places: the mitochondrial DNA passed from mother to child, and the nuclear DNA inherited from both parents.

The common thread is that every one of those genes plays a role in oxidative phosphorylation, the final stage of turning food into usable cellular fuel, a molecule called ATP. When the chain breaks anywhere along the line, neurons and muscle cells, the body’s heaviest energy users, start to starve.

Three Inheritance Patterns to Know

The genetic diversity of Leigh syndrome translates into three main inheritance routes that families may encounter during counseling:

  • Autosomal recessive: Both parents carry one mutated copy of a nuclear gene (such as SURF1) and pass the affected copy to the child. Each subsequent pregnancy carries a 25% risk.
  • X-linked recessive: A mutation on the X chromosome affects boys more severely because they have only one X chromosome. Girls may carry the mutation without symptoms.
  • Maternal (mitochondrial) inheritance: Mutations in mitochondrial DNA, including in the MT-ATP6 gene, pass from a mother to all her children, though severity varies depending on the proportion of faulty mitochondria each child inherits.

Why Two Children With the Same Diagnosis Can Look Different

A phenomenon called heteroplasmy complicates the picture. Each cell holds hundreds to thousands of mitochondria, and the ratio of mutated to healthy copies can shift between tissues. One sibling may inherit a high load of faulty mitochondria in the brain, while another inherits a lower load, leading to milder symptoms or even a later onset. That variability is one reason two children sharing the same clinical diagnosis can follow very different courses.

Symptoms and Early Signs Families Notice First

The earliest clues often look like a baby who was developing normally and then quietly begins to fall behind. You may notice a window of typical growth followed by a slow unraveling of skills your child had already mastered.

Because the disease attacks the brain’s motor and breathing centers first, the most common presenting signs cluster around movement, feeding, and respiration.

Motor Regression and Muscle Weakness

A child who once sat independently may stop sitting. A toddler who cruised along furniture may stop pulling to stand. Low muscle tone (hypotonia) and poor head control often show up first, followed by weakness that progresses over weeks or months rather than hours.

Breathing and Feeding Abnormalities

Episodes of hyperventilation, apnea (pauses in breathing), or irregular respiratory patterns reflect damage to the brainstem’s breathing control centers. Difficulty swallowing and poor weight gain, what clinicians call failure to thrive, frequently accompany the respiratory signs, sometimes leading families to seek feeding support before a diagnosis is reached.

Vision Changes Over Time

Optic atrophy, the gradual wasting of the nerve connecting the eye to the brain, can cause vision loss and abnormal eye movements, including slow drifting or jerky oscillations (nystagmus). These changes may not appear at onset but often develop as the disease advances.

Because so many of those signs overlap with more common childhood conditions, pediatricians rely on targeted testing to reach a definitive answer.

Tip: Document any loss of milestones with short videos on your phone. Timestamped clips of sitting, crawling, or walking can help a neurologist see the change more clearly than a verbal description months later.

How Clinicians Confirm the Diagnosis

Because it is rare and its early symptoms overlap with many other neurological conditions, diagnosis usually unfolds over weeks or months rather than at a single visit. Clinicians combine three lines of evidence: clinical examination, imaging and lab findings, and genetic testing.

Brain MRI as the Hallmark

Magnetic resonance imaging (MRI) is often the first strong clue. Characteristic bilateral lesions, meaning symmetric patches of damage visible on both sides of the brain, appear in the brainstem, basal ganglia, and thalamus. These lesions can change in size and intensity as the disease progresses, which is why follow-up imaging is common.

Blood, Spinal Fluid, and Muscle Studies

Elevated lactate in the blood or cerebrospinal fluid points to impaired energy metabolism, a condition known as lactic acidosis. When imaging and lactate results are ambiguous, a muscle biopsy may reveal ragged-red fibers, a classic microscopic sign of mitochondrial dysfunction, or reduced activity of respiratory chain enzymes such as cytochrome c oxidase (also called complex IV).

Genetic Testing Closes the Picture

A definitive diagnosis almost always requires identifying the specific mutation responsible. Multi-gene panels, and increasingly whole-exome or whole-genome sequencing, can pinpoint changes in nuclear genes like SURF1 or in mitochondrial genes like MT-ATP6. Knowing the exact mutation helps families understand recurrence risk and may open doors to mutation-specific clinical trials.

Diagnostic ToolWhat It DetectsTypical Role in Diagnosis
Brain MRISymmetric lesions in brainstem, basal ganglia, thalamusHallmark imaging finding; often triggers suspicion
Blood / CSF lactateElevated lactate signaling impaired energy metabolismSupportive biochemical evidence
Genetic testing panelsSpecific mutation in 75+ known genesConfirms diagnosis; guides family planning
Muscle biopsyRagged-red fibers; respiratory chain defectsUsed when imaging and genetics are inconclusive

Treatment Approaches and What Management Looks Like

No curative therapy exists for it today. Care focuses on slowing progression where possible, easing specific complications, and supporting quality of life for both the child and the family.

Your child’s management plan typically unfolds across several fronts at once, which is why most affected children are followed by a multidisciplinary team rather than a single specialist.

Supportive Supplements and Metabolic Strategies

Several supplements are commonly tried, though evidence for any of them varies by mutation and individual case. Thiamine (vitamin B1), riboflavin (vitamin B2), and coenzyme Q10 are frequently included because of their roles in mitochondrial energy pathways. Dietary strategies, including ketogenic or high-fat formulations, may help some children by providing an alternative fuel source for the brain. Always discuss any supplement or dietary change with your child’s metabolic specialist before starting it.

Managing Day-to-Day Complications

Respiratory support can range from supplemental oxygen during sleep to non-invasive ventilation as the disease progresses. Feeding tubes (nasogastric or gastrostomy) help children who can no longer swallow safely. Seizure management, physical therapy to maintain joint mobility, and vision support round out the practical side of daily care.

Because no therapy yet reverses the underlying neurodegeneration, conversations about prognosis and planning tend to follow closely behind the treatment plan.

Note: Management decisions are highly individualized. Work closely with a metabolic disease specialist and neurologist to build a plan that fits your child’s specific mutation and stage.

Prognosis, Life Expectancy, and Where Families Turn Next

it carries a serious prognosis. Most affected children experience a progressive neurological decline, and death typically occurs within 2 to 10 years of symptom onset, though some children survive longer, particularly those with milder mutations or strong supportive care.

What Shapes the Outlook

The underlying mutation matters more than almost any other factor. Children with certain nuclear gene mutations, such as SURF1, sometimes follow a slower course than those with MT-ATP6 or other mitochondrial DNA changes. Access to specialized care, respiratory support, and seizure control can extend both length and quality of life.

Emerging Research and Clinical Trials

Gene therapy and mitochondrial replacement techniques are active areas of investigation, though most remain in early research stages. Several patient registries and natural-history studies are enrolling families now, which means participation can contribute to the science while giving your child access to specialized monitoring. Specialist centers, often affiliated with academic medical schools, and rare disease foundations such as the United Mitochondrial Disease Foundation offer critical information, peer connection, and clinical-trial navigation.

Resources maintained by the National Institutes of Health (NIH) and the National Organization for Rare Disorders (NORD) provide regularly updated information on ongoing studies and approved care guidelines. Bringing those resources to your child’s care team can help align local treatment with the best available evidence.

The Big Picture

it is a severe, progressive mitochondrial disease that affects roughly 1 in 40,000 births, disrupts cellular energy production through mutations in dozens of possible genes, and leads to a steady loss of motor and breathing skills in early childhood. Early recognition, a thorough diagnostic workup that includes MRI and genetic testing, and a coordinated multidisciplinary care team give families the clearest path forward.

While no cure exists today, ongoing research into gene therapy and supportive metabolic strategies offers cautious reason to stay informed and connected to specialist centers.

FAQ

What is Leigh syndrome and how does it affect the body?

That rare inherited neurodegenerative disorder in which faulty mitochondria fail to produce enough cellular energy, damaging the brainstem, basal ganglia, and thalamus. The result is progressive loss of motor skills, muscle weakness, breathing abnormalities, and often vision problems, beginning in infancy or early childhood.

Is Leigh syndrome genetic or inherited?

Yes. More than 75 gene mutations can cause the disorder, and inheritance can follow autosomal recessive, X-linked, or maternal mitochondrial patterns depending on the specific gene involved. Genetic counseling helps families understand recurrence risk for future pregnancies.

What are the early signs of Leigh syndrome in infants?

Early signs include loss of previously gained motor skills such as sitting or crawling, low muscle tone, poor head control, episodes of abnormal breathing, and feeding difficulties. A gradual departure from prior developmental progress, rather than a single dramatic event, is what most families notice first.

How long do people with Leigh syndrome live?

Most affected children live between 2 and 10 years after symptoms begin, though some live longer with strong supportive care. The specific mutation, the speed of progression, and access to specialized medical support all influence the individual outlook.

Can Leigh syndrome be cured?

No cure exists today. Treatment focuses on slowing progression where possible, easing symptoms such as seizures and breathing difficulties, and supporting quality of life through supplements, dietary strategies, and multidisciplinary care.

How is Leigh syndrome diagnosed?

Diagnosis combines clinical evaluation, brain MRI showing characteristic bilateral lesions, elevated blood or cerebrospinal fluid lactate, and genetic testing to identify the specific mutation. Muscle biopsy is used in some cases when other results are inconclusive.

Staff
Staff

Our team brings together health and food enthusiasts who are passionate about discovering reliable health information, nutritious choices, and enjoyable food experiences. From everyday nutrition and healthy eating ideas to recipes, ingredients, food trends, and standout dishes, we share carefully researched and thoughtfully curated content to help readers make informed choices about what they eat and enjoy.